Abstract:Three clinicopathological phases of chronic hepatitis B virus (HBV) infection are identified. First, is immune tolerance of HBV. High levels of viraemia are associated with normal alanine aminotransferase (ALT) levels and minimal histological lesions. More than 30-40% of hepatocytes have the hepatitis B core antigen (HBcAg), predominantly in their nuclei. Maternally derived hepatitis B e antigen (HBeAg) crossing the placenta may result in the elimination of T helper cells responsive to HBeAg/HBcAg. This phase can last for periods ranging from a few weeks to 10 or more years until the immune tolerance is lost. Second, is the immune clearance of HBV. Intermediate levels of viraemia are associated with fluctuating ALT levels and active and ongoing hepatitis. Approximately 20-30% of hepatocytes have HBcAg, predominantly in their cytoplasm. Expression of pre-core defective HBV mutants during chronic HBV infection may lead to a reduction in the secretion of HBeAg and may trigger the beginning of the immuno-elimination phase. The mechanism of intrahepatic shift of HBcAg from the nucleus to the cytoplasm and the decreased levels of viraemia in this phase may be, at least in part, secondary to liver damage and regeneration. Third, is latent infection with residual integrated HBV. Undetectable viraemia is associated with normal ALT levels and no virus-induced liver damage. With regard to hepatocyte expression of HBsAg in chronic HBV infection, membrane staining of HBsAg on hepatocytes has been shown to correlate well with the presence of viraemia. The degree of cytoplasmic hepatitis B surface antigen (HBsAg) expression inversely correlates with the level of viraemia. Therefore, HBsAg carriers with high levels of viraemia have low levels of cytoplasmic hepatitis B surface antigen (HBsAg) expression, while those with low levels of viraemia have high levels of cytoplasmic HBsAg expression. However, several exceptions have been identified. High levels of viraemia associated with high levels of cytoplasmic HBsAg expression were recognized in patients with fibrosing cholestatic hepatitis. In contrast, low levels of viraemia associated with low levels of cytoplasmic HBsAg expression were recognized in patients with hepatitis C virus but not hepatitis D virus superinfection.

Hepatitis C virus in human B lymphocytes transformed by Epstein-Barr virus in vitro by in situ reverse transcriptase-polymerase chain reaction.

Study of Biologic Characteristics on Epstein-Barr Virus Transformed B Lymphocytes Carrying Hepatitis C Virus Type Ⅱ

Variation of Hypervariable Regions of the Genome of Hepatitis C Virus in EBV Transforming PBMC from Patients with Hepatitis C

Study on in Vitro Infection of Human Fetal Hepatocytes by Hepatitis C Virus

Identification of the Association Between HBcAg-specific T Cell and Viral Control in Chronic HBV Infection Using a Cultured ELISPOT Assay.

Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings

Hepatitis C Virus Replication in Stably Transfected HepG2 Cells Promotes Hepatocellular Growth and Tumorigenesis

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

A Chromogenic In Situ Hybridization (CISH) Assay for Detection of HBV RNA, DNA, and cccDNA in Liver Tissue

In Situ Analysis of Intrahepatic Virological Events in Chronic Hepatitis B Virus Infection.

DETECTION OF HEPATITIS C VIRUS IN PLASMA AND PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH CHRONIC HEPATITIS C BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION

A robust cell culture system supporting the complete life cycle of hepatitis B virus

STUDY ON PERIPHERAL BLOOD MONONUCLEAR CELL(PBMC) PROLIFERATIVE RESPONSES TO DIFFERENT HCV ANTIGENS IN PATIENTS WITH HEPATITIS C

Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV

Robust Production of Infectious Hepatitis C Virus (HCV) from Stably HCV Cdna-Transfected Human Hepatoma Cells

An Immortalized Hepatocyte-like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV

Natural history of chronic hepatitis B virus infection: An immunopathological study

Hepatitis B virus DNA and RNA persist in liver after serologic recovery in persons with hepatitis C virus

Effects Of Lymphocyte Co-Culture On Proliferation And Apoptosis Of Hepatitis B Virus (Hbv)-Expressing Normal Human Mesangial Cells (Nhmcs)

Centrifugal enhancement of hepatitis C virus infection of human hepatocytes.

Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women.